Live Analyst Rating Changes 1505 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Veronika Dubajova
Citi
Veronika Dubajova
Citi
Wall Street Analyst
★★★☆☆
#1045
on 13Foresight · ranked by our own returns
50%
Success Rate
+2.1%
Average Return
2 of 4 calls profitable · -5.1% vs benchmark
📈 Across the calls we could measure, roughly 50% of Veronika Dubajova's ratings turned a profit when each position was held for 1 year — averaging +2.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

33 Buy 7 Hold 10 Sell
Veronika's Stock Coverage 20 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
CH:STMN
Straumann Holding AG
 Jun 13, 2026 SELL Buy
+17.1% avg upside
13 analysts
$83.00
19.76% Downside
 ·
CH:ALC
Alcon
 Jun 11, 2026 BUY Buy
+35.5% avg upside
35 analysts
$81.62
55.42% Upside
 ·
GB:ONT
Oxford Nanopore Technologies PLC
 May 22, 2026 BUY Strong Buy
+80.6% avg upside
6 analysts
 — ·
GB:CTEC
ConvaTec
 May 18, 2026 HOLD Strong Buy
+41.1% avg upside
14 analysts
$230.00
12.11% Upside
 ·
GB:0K9P
GN Store Nord
 Apr 30, 2026 BUY Hold
+168.8% avg upside
13 analysts
$119.00
33.17% Upside
 ·
DE:FME
Fresenius Medical Care AG & Co. KGaA
 Apr 24, 2026 HOLD Buy
+26.4% avg upside
21 analysts
$40.00
3.33% Downside
 ·
DE:FRE
Fresenius SE & Co. KGaA
 Apr 24, 2026 BUY Strong Buy
+31.2% avg upside
19 analysts
$53.00
35.78% Upside
 ·
DE:SHL
Siemens Healthineers AG
 Apr 22, 2026 BUY Strong Buy
+51.5% avg upside
22 analysts
$53.00
52.98% Upside
 ·
WILLF
Demant
 Mar 11, 2026 BUY Strong Buy
+10.9% avg upside
19 analysts
 — +24.4%
FR:EL
EssilorLuxottica SA
 Feb 05, 2026 BUY Strong Buy
+12.1% avg upside
17 analysts
$315.00
80.23% Upside
 ·
NL:PHIA
Koninklijke Philips N.V.
 Jan 09, 2026 HOLD Buy
+33.0% avg upside
20 analysts
$25.00
7.95% Upside
 ·
GB:SN
Smith & Nephew
 Dec 15, 2025 BUY Strong Buy
+1304.3% avg upside
15 analysts
$1600.00
41.40% Upside
 ·
CH:SOON
Sonova Holding AG
 Oct 31, 2025 SELL Sell
+12.7% avg upside
17 analysts
 — ·
SE:EKTA.B
Elekta AB
 Jun 11, 2025 SELL Strong Sell
+24.0% avg upside
12 analysts
$39.00
19.04% Downside
 ·
IT:AMP
Amplifon S.p.A.
 Jun 05, 2025 HOLD Hold
+159.1% avg upside
12 analysts
$22.50
120.81% Upside
 ·
GB:0QBO
Coloplast A/S
 Jun 05, 2025 HOLD Buy
+86.3% avg upside
16 analysts
$700.00
84.63% Upside
 ·
DE:GXI
Gerresheimer
 Apr 07, 2022 BUY Buy
+143.2% avg upside
14 analysts
$110.00
328.40% Upside
 ·
ESLOY
EssilorLuxottica SA
 Jun 03, 2020 BUY Buy
+63.3% avg upside
2 analysts
$162.58
63.34% Upside
 +31.2%
FSNUY
Fresenius SE & Co
 Mar 22, 2019 BUY Strong Buy
-11.3% avg upside
6 analysts
 — -42.2%
SNN
Smith & Nephew Snats
 Mar 23, 2015 BUY Buy
+11.8% avg upside
13 analysts
 — -5.1%
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Veronika Dubajova — Frequently Asked Questions
How accurate are Veronika Dubajova's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Veronika's ratings were profitable over a one-year hold, with an average return of +2.1% per rating, or -5.1% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Veronika ranked on 13Foresight?
Veronika Dubajova is currently ranked #1045 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Veronika cover?
Veronika most recently has ratings on CH:STMN, CH:ALC, GB:ONT, GB:CTEC, GB:0K9P, DE:FME, DE:FRE, DE:SHL, WILLF, FR:EL, NL:PHIA, GB:SN and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.